0001457612-18-000014.txt : 20180212
0001457612-18-000014.hdr.sgml : 20180212
20180212202627
ACCESSION NUMBER: 0001457612-18-000014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180208
FILED AS OF DATE: 20180212
DATE AS OF CHANGE: 20180212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Poole Jonathan
CENTRAL INDEX KEY: 0001604689
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36289
FILM NUMBER: 18598730
MAIL ADDRESS:
STREET 1: C/O GENOCEA BIOSCIENCES, INC.
STREET 2: 100 ACORN PARK DRIVE, 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOCEA BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001457612
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 510596811
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-876-8191
MAIL ADDRESS:
STREET 1: 100 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: GENOCEA BIOSCIENCES INC
DATE OF NAME CHANGE: 20090304
4
1
wf-form4_151848517333702.xml
FORM 4
X0306
4
2018-02-08
0
0001457612
GENOCEA BIOSCIENCES, INC.
GNCA
0001604689
Poole Jonathan
C/O GENOCEA BIOSCIENCES, INC.
100 ACORN PARK DRIVE, 5TH FLOOR
CAMBRIDGE
MA
02140
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
0.98
2018-02-08
4
A
0
217708
0
A
2028-02-07
Common Stock
217708.0
217708
D
The options granted will vest annually in 48 equal monthly installments beginning on the first monthly anniversary of the grant date. The Company's Board of Directors also approved on February 8, 2018 that, subject to stockholder approval, Jonathan Poole will receive 257,292 additional options with the same grant date, at the same exercise price and pursuant to the same vesting schedule.
/s/ Jonathan Poole
2018-02-13